About us
The independent Institute for Quality and Efficiency in Health Care (Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen, IQWiG) examines the benefits and harms of medical interventions for patients.
Projects
Participation
Events
Press
Contact
Breadcrumbs
Presentations:
„The king of diseases“: How did the particular attention for patients with cancer come about? (German version)
Prof. Dr. med. Wolfgang Eckart
Medical treatment of cancer patients: Routine or something special? (German version)
Prof. Dr. med. Martin Schuler
Are there differences in the approval of oncologic drugs compared to non-oncologic ones? (German version)
Priv.-Doz. Dr. med. Harald Enzmann
HTA-Perspektiven: Sind Onkologika anders zu bewerten als andere Arzneimittel?
Priv.-Doz. Dr. phil. Claudia Wild
Viewed from the end of life: Is the question „cancer“ relevant to affected patients and carers? (German version)
Prof. Dr. med. Claudia Bausewein
Is less possible? Status of the discussion in Schweden (German version)
Prof. Dr. med. Jörg Carlsson
Less would actually be more: Drug therapy in elderly people (German version)
Prof. Dr. med. Petra Thürmann
One doesn´t need everything: Evidence-based medicine in practice (German version)
Dr. med. Wolfgang Blank
Is less allowed? The corridor between defensive medicine and under-provision of health care (German version)
Prof. Dr. Dr. Daniel Strech
Meeting programme
Short biographies of the speakers (German version)
